Ryota Sumitomo, Toshi Menju, Yumeta Shimazu, Toshiya Toyazaki, Naohisa Chiba, Hideaki Miyamoto, Yutaka Hirayama, Shigeto Nishikawa, Satona Tanaka, Yojiro Yutaka, et al. M2-like tumor-associated macrophages promote epithelial-mesenchymal transition through the transforming growth factor β/Smad/zinc finger e-box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma. Cancer science. 2023. 114. 12. 4521-4534
Ryo Miyata, Masatsugu Hamaji, Akiyoshi Nakakura, Satoshi Morita, Yumeta Shimazu, Masashi Ishikawa, Hidenao Kayawake, Toshi Menju, Yasuto Sakaguchi, Makoto Sonobe, et al. Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis. Surgery today. 2023. 53. 1. 135-144
Ryota Sumitomo, Cheng-Long Huang, Hidenori Ando, Tatsuhiro Ishida, Hiroyuki Cho, Hiroshi Date. Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non-small cell lung cancer. Oncology reports. 2022. 48. 5
Ryo Miyata, Masatsugu Hamaji, Atsushi Kawaguchi, Yumeta Shimazu, Masaki Ikeda, Masashi Ishikawa, Hidenao Kayawake, Toshi Menju, Masashi Kobayashi, Norihito Okumura, et al. Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR-mutated lung adenocarcinoma: a multi-institutional retrospective study. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2022. 62. 5
Ryota Sumitomo, Cheng-Long Huang, Masaaki Fujita, Hiroyuki Cho, Hiroshi Date. Differential expression of PD-L1 and PD-L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non-small cell lung cancer. Oncology reports. 2022. 47. 4
